Alain J. Cohen - Oct 4, 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Oct 4, 2021
Transactions value $
$9,988
Form type
4
Date filed
10/5/2021, 04:54 PM
Previous filing
Jul 7, 2021
Next filing
Jan 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Award $9.99K +222 $44.99 222 Oct 4, 2021 Direct F1, F2, F3
holding CCCC Common Stock 1.8M Oct 4, 2021 See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021.
F3 This amount has been adjusted to reflect 517 shares previously transferred from the Reporting Person to the Alain J. Cohen Revocable Trust.
F4 Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust.